The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke

on behalf of the NIH Natural History of Stroke Investigators

Research output: Contribution to journalArticle

Abstract

BACKGROUND AND PURPOSE: Timely restoration of tissue-level cerebral blood flow is the goal of thrombolytic therapy in patients presenting with an acute ischemic stroke. We aimed to identify the incidence and predictors of reperfusion immediately following treatment with intravenous recombinant tissue plasminogen activator (IV rt-PA). METHODS: This study included patients with acute ischemic stroke triaged using magnetic resonance imaging (MRI) with perfusion-weighted imaging (PWI) and treated with IV rt-PA who were subsequently enrolled in our natural history study and underwent repeat MRI with PWI approximately 2 hours posttreatment. Early reperfusion was defined as >80% decrease in the size of initial perfusion deficit on the 2 hours follow-up MRI. Demographics, stroke risk factors, presenting National Institutes of Health Stroke Scale score, and location of the thrombosis were compared between patients with and without early reperfusion. RESULTS: Of the 49 patients included in this study, 21 (43%) had early reperfusion. The mean age for patients with early reperfusion was significantly lower in comparison to the patients without early reperfusion (64 vs. 76, P =.01). The prevalence of hyperlipidemia was significantly lower among patients with early reperfusion (24% vs. 54%, P =.036). Patients with early reperfusion were less likely to have large-vessel occlusion (LVO) (internal carotid artery terminus or proximal middle cerebral artery) (24% vs. 50%, P =.06). In a multivariate analysis, the presence of an LVO was an independent predictor of lack of early reperfusion (OR [95%Cl]:.13 [.019-.89], P =.038). CONCLUSION: Early reperfusion was found in a substantial percentage of the patients treated with IV rt-PA. It was more common in patients without LVO.

Original languageEnglish (US)
Pages (from-to)206-210
Number of pages5
JournalJournal of Neuroimaging
Volume29
Issue number2
DOIs
StatePublished - Mar 1 2019
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Tissue Plasminogen Activator
Reperfusion
Stroke
Perfusion Imaging
Magnetic Resonance Imaging
Thrombolytic Therapy
Middle Cerebral Artery
National Institutes of Health (U.S.)
Internal Carotid Artery
Hyperlipidemias
Natural History

Keywords

  • Early reperfusion
  • intravenous recombinant tissue plasminogen activator
  • ischemic stroke
  • large-vessel occlusion
  • perfusion MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this

The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke. / on behalf of the NIH Natural History of Stroke Investigators.

In: Journal of Neuroimaging, Vol. 29, No. 2, 01.03.2019, p. 206-210.

Research output: Contribution to journalArticle

@article{58d06956efc14e6c917bfb7854078c2f,
title = "The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke",
abstract = "BACKGROUND AND PURPOSE: Timely restoration of tissue-level cerebral blood flow is the goal of thrombolytic therapy in patients presenting with an acute ischemic stroke. We aimed to identify the incidence and predictors of reperfusion immediately following treatment with intravenous recombinant tissue plasminogen activator (IV rt-PA). METHODS: This study included patients with acute ischemic stroke triaged using magnetic resonance imaging (MRI) with perfusion-weighted imaging (PWI) and treated with IV rt-PA who were subsequently enrolled in our natural history study and underwent repeat MRI with PWI approximately 2 hours posttreatment. Early reperfusion was defined as >80{\%} decrease in the size of initial perfusion deficit on the 2 hours follow-up MRI. Demographics, stroke risk factors, presenting National Institutes of Health Stroke Scale score, and location of the thrombosis were compared between patients with and without early reperfusion. RESULTS: Of the 49 patients included in this study, 21 (43{\%}) had early reperfusion. The mean age for patients with early reperfusion was significantly lower in comparison to the patients without early reperfusion (64 vs. 76, P =.01). The prevalence of hyperlipidemia was significantly lower among patients with early reperfusion (24{\%} vs. 54{\%}, P =.036). Patients with early reperfusion were less likely to have large-vessel occlusion (LVO) (internal carotid artery terminus or proximal middle cerebral artery) (24{\%} vs. 50{\%}, P =.06). In a multivariate analysis, the presence of an LVO was an independent predictor of lack of early reperfusion (OR [95{\%}Cl]:.13 [.019-.89], P =.038). CONCLUSION: Early reperfusion was found in a substantial percentage of the patients treated with IV rt-PA. It was more common in patients without LVO.",
keywords = "Early reperfusion, intravenous recombinant tissue plasminogen activator, ischemic stroke, large-vessel occlusion, perfusion MRI",
author = "{on behalf of the NIH Natural History of Stroke Investigators} and Shahram Majidi and Simpkins, {Alexis N.} and Richard Leigh",
year = "2019",
month = "3",
day = "1",
doi = "10.1111/jon.12587",
language = "English (US)",
volume = "29",
pages = "206--210",
journal = "Journal of Neuroimaging",
issn = "1051-2284",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke

AU - on behalf of the NIH Natural History of Stroke Investigators

AU - Majidi, Shahram

AU - Simpkins, Alexis N.

AU - Leigh, Richard

PY - 2019/3/1

Y1 - 2019/3/1

N2 - BACKGROUND AND PURPOSE: Timely restoration of tissue-level cerebral blood flow is the goal of thrombolytic therapy in patients presenting with an acute ischemic stroke. We aimed to identify the incidence and predictors of reperfusion immediately following treatment with intravenous recombinant tissue plasminogen activator (IV rt-PA). METHODS: This study included patients with acute ischemic stroke triaged using magnetic resonance imaging (MRI) with perfusion-weighted imaging (PWI) and treated with IV rt-PA who were subsequently enrolled in our natural history study and underwent repeat MRI with PWI approximately 2 hours posttreatment. Early reperfusion was defined as >80% decrease in the size of initial perfusion deficit on the 2 hours follow-up MRI. Demographics, stroke risk factors, presenting National Institutes of Health Stroke Scale score, and location of the thrombosis were compared between patients with and without early reperfusion. RESULTS: Of the 49 patients included in this study, 21 (43%) had early reperfusion. The mean age for patients with early reperfusion was significantly lower in comparison to the patients without early reperfusion (64 vs. 76, P =.01). The prevalence of hyperlipidemia was significantly lower among patients with early reperfusion (24% vs. 54%, P =.036). Patients with early reperfusion were less likely to have large-vessel occlusion (LVO) (internal carotid artery terminus or proximal middle cerebral artery) (24% vs. 50%, P =.06). In a multivariate analysis, the presence of an LVO was an independent predictor of lack of early reperfusion (OR [95%Cl]:.13 [.019-.89], P =.038). CONCLUSION: Early reperfusion was found in a substantial percentage of the patients treated with IV rt-PA. It was more common in patients without LVO.

AB - BACKGROUND AND PURPOSE: Timely restoration of tissue-level cerebral blood flow is the goal of thrombolytic therapy in patients presenting with an acute ischemic stroke. We aimed to identify the incidence and predictors of reperfusion immediately following treatment with intravenous recombinant tissue plasminogen activator (IV rt-PA). METHODS: This study included patients with acute ischemic stroke triaged using magnetic resonance imaging (MRI) with perfusion-weighted imaging (PWI) and treated with IV rt-PA who were subsequently enrolled in our natural history study and underwent repeat MRI with PWI approximately 2 hours posttreatment. Early reperfusion was defined as >80% decrease in the size of initial perfusion deficit on the 2 hours follow-up MRI. Demographics, stroke risk factors, presenting National Institutes of Health Stroke Scale score, and location of the thrombosis were compared between patients with and without early reperfusion. RESULTS: Of the 49 patients included in this study, 21 (43%) had early reperfusion. The mean age for patients with early reperfusion was significantly lower in comparison to the patients without early reperfusion (64 vs. 76, P =.01). The prevalence of hyperlipidemia was significantly lower among patients with early reperfusion (24% vs. 54%, P =.036). Patients with early reperfusion were less likely to have large-vessel occlusion (LVO) (internal carotid artery terminus or proximal middle cerebral artery) (24% vs. 50%, P =.06). In a multivariate analysis, the presence of an LVO was an independent predictor of lack of early reperfusion (OR [95%Cl]:.13 [.019-.89], P =.038). CONCLUSION: Early reperfusion was found in a substantial percentage of the patients treated with IV rt-PA. It was more common in patients without LVO.

KW - Early reperfusion

KW - intravenous recombinant tissue plasminogen activator

KW - ischemic stroke

KW - large-vessel occlusion

KW - perfusion MRI

UR - http://www.scopus.com/inward/record.url?scp=85058041962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058041962&partnerID=8YFLogxK

U2 - 10.1111/jon.12587

DO - 10.1111/jon.12587

M3 - Article

C2 - 30508260

AN - SCOPUS:85058041962

VL - 29

SP - 206

EP - 210

JO - Journal of Neuroimaging

JF - Journal of Neuroimaging

SN - 1051-2284

IS - 2

ER -